Letter to medicines and medical products suppliers: 3 August 2020

DHSC's Chief Commercial Officer wrote to medicine suppliers, supply chain and businesses.



The UK government and the European Commission have concluded their negotiations on the terms of trade between the 2 markets after the end of the transition period.

This does not remove any of the requirements to act now to prepare for new customs and border processes. The Department’s requests of industry set out in this letter remain valid and current.

This letter is written by Steve Oldfield, Chief Commercial Officer, on behalf of the Department of Health and Social Care (DHSC).

It sets out the government’s plan and requests of industry and the wider supply chain ahead of the end of the transition period to help ensure the continuity of supply of medical goods into and out of the UK.

See also DHSC’s update letter to industry of 17 November.

Published 3 August 2020
Last updated 28 December 2020 + show all updates
  1. Added message that DHSC's requests of industry set out in this letter remain valid and current, after the trade and cooperation agreement reached between the EU and the UK.

  2. Based on wider consultation and feedback, we have updated the letter to include mention of the cross-government reasonable worst case scenario (RWCS) being used for planning purposes and some of the fundamentals of those assumptions, including the time-limited nature of any potential disruption.

  3. First published.